Found 7 matching trials
Bioavailability Study of K0706 in Healthy Subjects PHASE1 This is single-center, single-dose, randomized, open-label, four-period, fo...
Show More Learn More & Join Trial
Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies PHASE1 Phase 1/2 study to determine safety, tolerability, pharmacokinetics, and an...
Show More Location
The Oncology Institute of Hope and Innovation, Innovative Clinical Research Institute
Learn More & Join Trial
To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers PHASE1 This is an open-label, multiple-dose study to evaluate the plasma and CSF p...
Show More Learn More & Join Trial
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706 PHASE2 This study consists of 2 parts. Part 1 of the study is conducted to evaluat...
Show More Location
Xenoscience Inc. - 21st Century Neurology
Learn More & Join Trial
Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous Treatments N/A The main study (CLR\_15\_03) was terminated prematurely for non-safety reas...
Show More Status
Temporarily Not Available
Location
Georgia Cancer Center at Augusta University
Learn More & Join Trial
Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease PHASE1 This is a safety, tolerability and pharmacokinetic study in subjects with P...
Show More Learn More & Join Trial
K0706 for Patients Diagnosed With Dementia With Lewy Bodies PHASE2 This study evaluates the safety and tolerability of treatment with K0706 in...
Show More Location
MedStar Georgetown University Hospital
Learn More & Join Trial